Conjunctivitis Drugs Market Share Size GlobalGathering and Future Outlook 2020 to 2027
Conjunctivitis is an eye condition characterized byinflammation of external white part and eyelids. Although this medicalcondition is caused due to various factors but bacterial and virus are mostprominent causes accounting for more than 50% cases of conjunctivitis. The market for conjunctivitis drugs is facingstagnant growth in developed regions. Also, a number of patents which haveexpired such as Moxeza, Besivance, Vigamox, and Zymaxid have dampened the market growth. The market is further characterized by easy entry but high competition which has resulted into greater penetration by generics.
ConjunctivitisDrugs Market Share Is Expected to Grow at a CAGR of 3.1% by 2022 .The beststrategy for firms is market development especially the Asian Pacific marketwhich is poised to lead the growth of the global market in the near future. Themarket is further dampened by the better efficacy and broad spectrum ofanti-bacterial drugs led by quinolones. Quinolones especially Fluoroquinolones has a dominant market share for conjunctivitis. The research pipeline is somewhat weak with many other classes of antibiotics exhibiting greater toxicity. Thus, quinolones have immensely raised the acceptable bar for newer drugs.
The market is chiefly driven by unmet needs in developingregions along with greater awareness and rising incomes in these regions. Thesereasons along with contagious nature of the disease along with rise of drugresistance also driving the market of other antibiotics which has greatertoxicity such as macrolide class. Off label drug use is also one of the market drivers due to cheap generics and greater availability of these drugs.
Test the market data and market information presented inmore than 60 market data tables and figures spread over 84 pages of the projectreport. Avail the in-depth table of content (TOC) & market synopsis on “TheGlobal Conjunctivitis Drugs Market Research Report - Forecast to 2022”.
Global Conjunctivitis Drugs market:
The global conjunctivitis drugs market has been evaluated tobe growing and it is expected that it will touch high growth figures in future.The global conjunctivitis drugs market is expected to grow with CAGR of 3.1% infuture. Market development and diversification into Asian Pacific market seemsto have better strategy for the current situation.
Market Key Players:
Major participants of this market are: AkornPharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, ValeantPharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc. and others.
Segmentation:
Global conjunctivitis drugs market has been segmented on thebasis of conjunctivitis type which comprises of viral, bacterial, allergic andothers types of conjunctivitis. On the basis of drug class; market is segmentedinto antibiotics (quinolones, aminoglycosides, macrolides and others), mastcell stabilizers, steroids and others. On the basis of route of administration; market is segmented into topical, oral and intra-vitreal. On the basis of end users; market is segmented into hospitals and self-administered.
Regional Analysis:
Depending on geographic region, conjunctivitis drugs marketis segmented into four key regions: America, Europe, Asia Pacific, and MiddleEast & Africa. Globally, America is the largest market for conjunctivitisdrugs followed by Europe. However, the developed regions market is stagnant andany future growth will be led by the developing regions especially Asia pacific region. The unmet drug needs and greater awareness are prime driver of the conjunctivitis drugs market. Greater exposure to allergens and infective agents is also driving the market’s growth.
About MarketResearch Future:
At Market ResearchFuture (MRFR), we enable our customers to unravel the complexity of variousindustries through our Cooked Research Report (CRR), Half-Cooked ResearchReports (HCRR), & Consulting Services. MRFR team have supreme objective toprovide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market ResearchFuture
+1 646 845 9312
Email: sales@marketresearchfuture.com